There’s no doubt that the Sunshine Act provisions of the Affordable Care Act, which require pharmaceutical companies to track and publicly report what they spend on U.S. healthcare providers, will make life more difficult for life sciences meeting planners. But it gets even more complicated when you take your meetings outside the U.S. and have to deal both with the rules of the event’s host country and those of your healthcare provider attendees. As Peter Burberry, senior ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Tracking Global Physician Spend , you'll get exclusive access to a large archive of premium content.

Already registered? here.